Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327 pISSN 1738-1088

Cited by CrossRef (104)

  1. Sepideh Fallahi, Łukasz Bobak, Sebastian Opaliński. Hemp in Animal Diets—Cannabidiol. Animals 2022;12:2541
    https://doi.org/10.3390/ani12192541
  2. Serge Perrot, Anne-Priscille Trouvin. Cannabis for musculoskeletal pain and arthritis: Evidence is needed. Joint Bone Spine 2019;86:1
    https://doi.org/10.1016/j.jbspin.2018.03.004
  3. Feline Hamami, Tobias Bäumer. Schmerzen bei zervikaler Dystonie. Schmerz 2024;38:41
    https://doi.org/10.1007/s00482-024-00790-5
  4. Sara Anna Bonini, Marika Premoli, Simone Tambaro, Amit Kumar, Giuseppina Maccarinelli, Maurizio Memo, Andrea Mastinu. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of Ethnopharmacology 2018;227:300
    https://doi.org/10.1016/j.jep.2018.09.004
  5. Natalia Szejko, Florian Burger, Victoria Sidoroff, Gregor K. Wenning. Case Report: Secondary bilateral parkinsonism and dystonia treated with dronabinol. F1000Res 2021;9:1162
    https://doi.org/10.12688/f1000research.26476.3
  6. Susan J. Thanabalasingam, Brandan Ranjith, Robyn Jackson, Don Thiwanka Wijeratne. Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis. Ther Adv Neurol Disord 2021;14
    https://doi.org/10.1177/17562864211018561
  7. E. Hoch, N. D. Volkow, C. M. Friemel, V. Lorenzetti, T. P. Freeman, W. Hall. Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. Eur Arch Psychiatry Clin Neurosci 2024
    https://doi.org/10.1007/s00406-024-01880-2
  8. D. M. Wolfe, C. Hamel, D. Rice, A. A. Veroniki, B. Skidmore, S. Kanji, K. Rabheru, S. F. McGee, L. Forbes, M. Liu, D. Saunders, L. Vandermeer, I. Machado de Lima, M. Clemons, B. Hutton. Comparative effectiveness of interventions for cancer treatment–related cognitive impairment in adult cancer survivors: protocol for a systematic review. Syst Rev 2024;13
    https://doi.org/10.1186/s13643-024-02602-4
  9. Douglas E. Brenneman, William A. Kinney, Sara Jane Ward. Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity. J Mol Neurosci 2019;68:603
    https://doi.org/10.1007/s12031-019-01321-z
  10. A.-P. Trouvin, S. Perrot. Cannabis : enjeux et risques en médecine de la douleur. Douleur analg 2019;32:73
    https://doi.org/10.3166/dea-2019-0062
  11. Kylie O’Brien, Philip Blair. Medicinal Cannabis and CBD in Mental Healthcare. 2019.
    https://doi.org/10.1007/978-3-030-78559-8_11
  12. Carla Alves, Wagner Antonio Tamagno, Ana Paula Vanin, Aline Pompermaier, Leonardo José Gil Barcellos. Cannabis sativa-based oils against aluminum-induced neurotoxicity. Sci Rep 2023;13
    https://doi.org/10.1038/s41598-023-36966-9
  13. Katarzyna Woźniczka, Paweł Konieczyński, Alina Plenis, Tomasz Bączek, Anna Roszkowska. SPME as a green sample-preparation technique for the monitoring of phytocannabinoids and endocannabinoids in complex matrices. Journal of Pharmaceutical Analysis 2023;13:1117
    https://doi.org/10.1016/j.jpha.2023.06.014
  14. Iqra Kalsoom, Kiran Shehzadi, Han-sheng Li, Hong-liang Wen, Ming-jia Yu. Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview. Top Curr Chem (Z) 2024;382
    https://doi.org/10.1007/s41061-024-00465-w
  15. Herman Johal, Christopher Vannabouathong, Yaping Chang, Meng Zhu, Mohit Bhandari. Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use?. Therapeutic Advances in Musculoskeletal 2020;12
    https://doi.org/10.1177/1759720X20937968
  16. Priya Gupta, Archu Singh, Sadat Shafi, Tanya Ralli, Faheem Hyder Pottoo, Yasmin Sultana, Kanchan Kohli. Cannabis sativa in Phytotherapy: Reappraisal of Therapeutic Potential and Regulatory Aspects. CPB 2024;25:58
    https://doi.org/10.2174/1389201024666230508142114
  17. Catalina Pérez-Olives, Rafael Rivas-Santisteban, Jaume Lillo, Gemma Navarro, Rafael Franco. Cannabinoids and Neuropsychiatric Disorders. 2024.
    https://doi.org/10.1007/978-3-030-57369-0_6
  18. Darcy Fehlings, Brenda Agnew, Hortensia Gimeno, Adrienne Harvey, Kate Himmelmann, Jean‐Pierre Lin, Jonathan W. Mink, Elegast Monbaliu, James Rice, Emma Bohn, Yngve Falck‐Ytter. Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update. Develop Med Child Neuro 2024;66:1133
    https://doi.org/10.1111/dmcn.15921
  19. Andrzej Silczuk, Daria Smułek, Marcin Kołodziej, Julia Gujska. The Construct of Medical and Non-Medical Marijuana—Critical Review. IJERPH 2022;19:2769
    https://doi.org/10.3390/ijerph19052769
  20. Graziella dos Reis Rosa Franco, Scott Smid, Cláudio Viegas . Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases. CN 2021;19:449
    https://doi.org/10.2174/1570159X18666200720172624
  21. Gustavo A. Da Prat de Magalhaes, Martin Cesarini, Natalia Gonzalez Rojas, Jose Luis Etcheverry, Galeno J. Rojas, Virginia L. Parisi, Gabriel G. Persi, Juan Felipe Peralta Calderón, Diego Díaz, Emilia M. Gatto. Estudio de registro de pacientes con desórdenes del movimiento con autoprescripción de formas no estandarizadas de cannabis. Experiencia de un centro especializado en movimientos anormales de Buenos Aires. Neurología Argentina 2020;12:165
    https://doi.org/10.1016/j.neuarg.2020.04.003
  22. Catherine A. Dennen, Kenneth Blum, Abdalla Bowirrat, Jag Khalsa, Panayotis K. Thanos, David Baron, Rajendra D. Badgaiyan, Ashim Gupta, Eric R. Braverman, Mark S. Gold. Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes 2022;6:27
    https://doi.org/10.3390/epigenomes6030027
  23. Per Damkier, Dorte Lassen, Mette Marie Hougaard Christensen, Kenneth Grønkjær Madsen, Maja Hellfritzsch, Anton Pottegård. Interaction between warfarin and cannabis. Basic Clin Pharma Tox 2019;124:28
    https://doi.org/10.1111/bcpt.13152
  24. Ran Abuhasira, Lihi Bar-Lev Schleider, Raphael Mechoulam, Victor Novack. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine 2018;49:44
    https://doi.org/10.1016/j.ejim.2018.01.019
  25. Shubh Pravat Singh Yadav, Monika Kafle, Netra Prasad Ghimire, Nitesh Kumar Shah, Prasanna Dahal, Subarna Pokhrel. An overview of phytochemical constituents and pharmacological implications of Cannabis sativa L.. Journal of Herbal Medicine 2023;42:100798
    https://doi.org/10.1016/j.hermed.2023.100798
  26. Gholamreza Komeili, Elham Haghparast, Vahid Sheibani. Marijuana improved motor impairments and changes in synaptic plasticity-related molecules in the striatum in 6-OHDA-treated rats. Behavioural Brain Research 2021;410:113342
    https://doi.org/10.1016/j.bbr.2021.113342
  27. Laura MacNair, Maja Kalaba, Erica N. Peters, Matthew T. Feldner, Graham M. L. Eglit, Lucile Rapin, Cynthia El Hage, Erin Prosk, Mark A. Ware. Medical cannabis authorization patterns, safety, and associated effects in older adults. J Cannabis Res 2022;4
    https://doi.org/10.1186/s42238-022-00158-5
  28. Daryl Efron, Kaitlyn Taylor, Jonathan M Payne, Jeremy L Freeman, Noel Cranswick, Melissa Mulraney, Chidambaram Prakash, Katherine J Lee, Katrina Williams. Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trial. BMJ Open 2020;10:e034362
    https://doi.org/10.1136/bmjopen-2019-034362
  29. Ran Abuhasira, Yosef S. Haviv, Merav Leiba, Adi Leiba, Larisa Ryvo, Victor Novack. Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study. European Journal of Internal Medicine 2021;86:79
    https://doi.org/10.1016/j.ejim.2021.01.005
  30. Kanchan Kohli, Arjun Singh Dasoondi, Priya Gupta, Shwetakshi Sharma, Tanya Ralli. Cannabis and Derivatives. 2021.
    https://doi.org/10.1016/B978-0-443-15489-8.00007-4
  31. Natalia Szejko, Florian Burger, Victoria Sidoroff, Gregor K. Wenning. Case Report: Secondary bilateral parkinsonism and dystonia treated with dronabinol. F1000Res 2020;9:1162
    https://doi.org/10.12688/f1000research.26476.2
  32. Douglas E. Brenneman, Dean Petkanas, William A. Kinney. Pharmacological Comparisons Between Cannabidiol and KLS-13019. J Mol Neurosci 2018;66:121
    https://doi.org/10.1007/s12031-018-1154-7
  33. Garrett Rossi , Joan C Oh. Management of Agitation in Huntington’s Disease: A Review of the Literature. 2020
    https://doi.org/10.7759/cureus.9748
  34. Hao Chen, Yaqi Liu, Sijing Yu, Cheng Li, Bo Gao, Xuedong Zhou. Cannabidiol attenuates periodontal inflammation through inhibiting TLR4/NF‐κB pathway. J of Periodontal Research 2023;58:697
    https://doi.org/10.1111/jre.13118
  35. Amir Minerbi, Winfried Häuser, Mary-Ann Fitzcharles. Medical Cannabis for Older Patients. Drugs Aging 2019;36:39
    https://doi.org/10.1007/s40266-018-0616-5
  36. Dianna Wolfe, Kimberly Corace, Danielle Rice, Andra Smith, Salmaan Kanji, David Conn, Melanie Willows, Gary E Garber, John Puxty, Esther Moghadam, Becky Skidmore, Chantelle Garritty, Kednapa Thavorn, David Moher, Brian Hutton. Effects of medical and non-medical cannabis use in older adults: protocol for a scoping review. BMJ Open 2020;10:e034301
    https://doi.org/10.1136/bmjopen-2019-034301
  37. Leonie M. Milosev, Nikolas Psathakis, Natalia Szejko, Ewgeni Jakubovski, Kirsten R. Müller-Vahl. Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey. Cannabis and Cannabinoid Research 2019;4:265
    https://doi.org/10.1089/can.2018.0050
  38. Dianna Wolfe, Kim Corace, Claire Butler, Danielle Rice, Becky Skidmore, Yashila Patel, Premika Thayaparan, Alan Michaud, Candyce Hamel, Andra Smith, Gary Garber, Amy Porath, David Conn, Melanie Willows, Hanan Abramovici, Kednapa Thavorn, Salmaan Kanji, Brian Hutton, Francesca Baratta. Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature. PLoS ONE 2023;18:e0281826
    https://doi.org/10.1371/journal.pone.0281826
  39. John Michael Austin, Ryan Bailey, Sandra Garcia Velazquez, Harinandan Sainath, Carlayne Jackson. Clinical effectiveness of medical marijuana in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2024;466:123243
    https://doi.org/10.1016/j.jns.2024.123243
  40. Ran Abuhasira, Lihi Schwartz, Victor Novack. Medical Cannabis Is Not Associated with a Decrease in Activities of Daily Living in Older Adults. Biomedicines 2023;11:2697
    https://doi.org/10.3390/biomedicines11102697
  41. Abhijit Dey, Banadipa Nanda, Samapika Nandy, Anuradha Mukherjee, Devendra Kumar Pandey. Bioactive Natural Products. 2023.
    https://doi.org/10.1016/B978-0-12-819483-6.00002-3
  42. Hillary D. Lum, Kanika Arora, J. Alton Croker, Sara H. Qualls, Melissa Schuchman, Julie Bobitt, Gary Milavetz, Brian Kaskie. Patterns of Marijuana Use and Health Impact: A Survey Among Older Coloradans. Gerontology and Geriatric Medicine 2019;5
    https://doi.org/10.1177/2333721419843707
  43. Lauren J. Rice, Lisa Cannon, Navin Dadlani, Melissa Mei Yin Cheung, Stewart L. Einfeld, Daryl Efron, David R. Dossetor, Elizabeth J. Elliott. Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review. Eur Child Adolesc Psychiatry 2024;33:505
    https://doi.org/10.1007/s00787-023-02169-w
  44. . Rational Psychopharmacology: A Book of Clinical Skills. 2024.
    https://doi.org/10.1176/appi.books.9781615379569.lg09
  45. Joseph Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer Goldman. Principles and Practice of Movement Disorders. 2024.
    https://doi.org/10.1016/B978-0-323-31071-0.00015-9
  46. Matthew Butler, Mathieu Seynaeve, Abigail Bradley-Westguard, Jianan Bao, Ania Crawshaw, Susannah Pick, Mark Edwards, Timothy Nicholson, James Rucker. Views on Using Psychoactive Substances to Self-Manage Functional Neurological Disorder: Online Patient Survey Results. JNP 2023;35:77
    https://doi.org/10.1176/appi.neuropsych.21080213
  47. Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, Earl J. Morris, Golnoosh Alipour-Haris, Juan M. Hincapie-Castillo, Nichole E. Stetten, Ruba Sajdeya, Shailina Keshwani, Verlin Joseph, Yahan Zhang, Yun Shen, Lauren Adkins, Almut G. Winterstein, Amie Goodin. A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Med Cannabis Cannabinoids 2021;4:21
    https://doi.org/10.1159/000515069
  48. Kirsten R. Müller-Vahl. Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature. Pharmacopsychiatry 2024;57:104
    https://doi.org/10.1055/a-2256-0098
  49. Andrew G. Mtewa. Cannabis and Khat in Drug Discovery. 2024.
    https://doi.org/10.1016/B978-0-323-95927-8.00029-3
  50. Anthony M. Downs, Kaitlyn M. Roman, Simone A. Campbell, Antonio Pisani, Ellen J. Hess, Paola Bonsi. The neurobiological basis for novel experimental therapeutics in dystonia. Neurobiology of Disease 2019;130:104526
    https://doi.org/10.1016/j.nbd.2019.104526
  51. Felix-Martin Werner, Rafael Coveñas. Comparison of Mono-dopaminergic and Multi-target Pharmacotherapies in Primary Parkinson Syndrome and Assessment Tools to Evaluate Motor and Non-motor Symptoms. CDTH 2019;14:124
    https://doi.org/10.2174/1574885513666181115104137
  52. Jennifer Rup, Tom P. Freeman, Chris Perlman, David Hammond. Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status. Substance Use & Misuse 2022;57:719
    https://doi.org/10.1080/10826084.2022.2034872
  53. Raja Babu, Abhipsa Mohapatra, Amarjeet, Debapriya Garabadu. Cannabis and Derivatives. 2022.
    https://doi.org/10.1016/B978-0-443-15489-8.00004-9
  54. Renata Rizzo, Mariangela Gulisano. Treatment Resistance in Psychiatry. 2022.
    https://doi.org/10.1007/978-981-10-4358-1_16
  55. Konstantinos Mesiakaris, Korina Atsopardi, George Lagoumintzis, Marigoula Margarity, Konstantinos Poulas. Cannabidiol Modulation of Nicotine‐Induced Toxicity: Assessing Effects on Behavior, Brain‐Derived Neurotrophic Factor, and Oxidative Stress in C57BL/6 Male Mice. J of Neuroscience Research 2024;102
    https://doi.org/10.1002/jnr.25384
  56. John D. Outen, M. Haroon Burhanullah, Ryan Vandrey, Halima Amjad, David G. Harper, Regan E. Patrick, Rose L. May, Marc E. Agronin, Brent P. Forester, Paul B. Rosenberg. Cannabinoids for Agitation in Alzheimer's Disease. The American Journal of Geriatric Psychiatry 2021;29:1253
    https://doi.org/10.1016/j.jagp.2021.01.015
  57. Jeremy Y. Ng, Amanda Abrams, Ananya Pathak, Umair Tahir, Jane Jomy. What are the experiences of patients using cannabis for pain? A systematic review of qualitative studies. European Journal of Integrative Medicine 2022;49:102098
    https://doi.org/10.1016/j.eujim.2021.102098
  58. Andrea Mastinu, Marika Premoli, Giulia Ferrari-Toninelli, Simone Tambaro, Giuseppina Maccarinelli, Maurizio Memo, Sara Anna Bonini. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation. 2018;36
    https://doi.org/10.1515/hmbci-2018-0013
  59. Cecilia Costiniuk, Caroline A. MacCallum, Michael Boivin, Sergio Rueda, Gary Lacasse, Zach Walsh, Paul J. Daeninck, Shari Margolese, Enrico Mandarino, Jagpaul Kaur Deol, Tatiana Sanchez, Alan D. Bell. Why a distinct medical stream is necessary to support patients using cannabis for medical purposes. J Cannabis Res 2023;5
    https://doi.org/10.1186/s42238-023-00195-8
  60. Jacopo Lamanna, Mattia Ferro, Sara Spadini, Gabriella Racchetti, Antonio Malgaroli. The Dysfunctional Mechanisms Throwing Tics: Structural and Functional Changes in Tourette Syndrome. Behavioral Sciences 2023;13:668
    https://doi.org/10.3390/bs13080668
  61. Alessia Furgiuele, Marco Cosentino, Marco Ferrari, Franca Marino. Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review. J Neuroimmune Pharmacol 2021;16:251
    https://doi.org/10.1007/s11481-021-09982-7
  62. Sinemyiz Atalay, Iwona Jarocka-Karpowicz, Elzbieta Skrzydlewska. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants 2019;9:21
    https://doi.org/10.3390/antiox9010021
  63. . Individualize treatment when prescribing medical cannabis to older patients as efficacy data remains limited. Drugs Ther Perspect 2019;35:486
    https://doi.org/10.1007/s40267-019-00658-0
  64. Serge Perrot, Anne-Priscille Trouvin. Le cannabis dans les douleurs musculosquelettiques et articulaires : des preuves sont nécessaires. Revue du Rhumatisme 2019;86:215
    https://doi.org/10.1016/j.rhum.2019.03.009
  65. Run Ma, Na Xie, Yuanhui Shu, Yafeng Wu, Ping He, Yining Xiang, Yan Zhou, Yuping Wang. Cannabidiol alleviates carbon tetrachloride-induced liver fibrosis in mice by regulating NF-κB and PPAR-α pathways. Exp. Biol. Med. 2024;249
    https://doi.org/10.3389/ebm.2024.10141
  66. Aurélie Revol. «  Au moins on tente quelque chose  » : cannabis thérapeutique et lien social. 2022;vol. 44 / n° 167:215
    https://doi.org/10.3917/gs1.167.0215
  67. Farhang Modaresi, Kaivan Talachian. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes. Pharm Med 2022;36:387
    https://doi.org/10.1007/s40290-022-00447-7
  68. Horia Paunescu, Lorena Dima, Isabel Ghita, Laurenţiu Coman, Petru Iulian Ifteni, Ion Fulga, Oana Andreia Coman. A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia. 2020;27:e249
    https://doi.org/10.1097/MJT.0000000000001120
  69. Jodie Belinda Hillen, Natalie Soulsby, Chris Alderman, Gillian E. Caughey. Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review. Therapeutic Advances in Drug Safety 2019;10
    https://doi.org/10.1177/2042098619846993
  70. Ochuko L. Erukainure, Motlalepula G. Matsabisa, Veronica F. Salau, Md. Shahidul Islam. Tetrahydrocannabinol-Rich Extracts From Cannabis Sativa L. Improve Glucose Consumption and Modulate Metabolic Complications Linked to Neurodegenerative Diseases in Isolated Rat Brains. Front. Pharmacol. 2020;11
    https://doi.org/10.3389/fphar.2020.592981
  71. P. Oikonomou, W. H. Jost. Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review. J Neural Transm 2022;129:1247
    https://doi.org/10.1007/s00702-022-02529-x
  72. Rachel Riera, Rafael Leite Pacheco, Ângela Maria Bagattini, Ana Luiza Cabrera Martimbianco. Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews. Phytotherapy Research 2022;36:5
    https://doi.org/10.1002/ptr.7263
  73. Dina Bosnjak Kuharic, Domagoj Markovic, Tonci Brkovic, Milka Jeric Kegalj, Zana Rubic, Ana Vuica Vukasovic, Ana Jeroncic, Livia Puljak. Cannabinoids for the treatment of dementia. 2021;2021
    https://doi.org/10.1002/14651858.CD012820.pub2
  74. Amnon A. Berger, Joseph Keefe, Ariel Winnick, Elasaf Gilbert, Jonathan P. Eskander, Cyrus Yazdi, Alan D. Kaye, Omar Viswanath, Ivan Urits. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best Practice & Research Clinical Anaesthesiology 2020;34:617
    https://doi.org/10.1016/j.bpa.2020.08.010
  75. Clara M. Vecchini Rodríguez, Yma Escalona Meléndez, Jacqueline Flores-Otero. Cannabinoids and Sleep. 2020.
    https://doi.org/10.1007/978-3-030-61663-2_4
  76. Yue Zhang, Hongyuan Li, Sha Jin, Yuyuan Lu, Yinghua Peng, Lihui Zhao, Xiaohui Wang. Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups. European Journal of Pharmacology 2022;919:174829
    https://doi.org/10.1016/j.ejphar.2022.174829
  77. Offer E. Edelstein, Oren Wacht, Richard Isralowitz, Alexander Reznik, Yaacov G. Bachner. Beliefs and Attitudes of Graduate Gerontology Students about Medical Marijuana Use for Alzheimer’s and Parkinson’s Disease. Complementary Therapies in Medicine 2020;52:102418
    https://doi.org/10.1016/j.ctim.2020.102418
  78. Mariana Babayeva, Zvi G. Loewy. Cannabis Pharmacogenomics: A Path to Personalized Medicine. CIMB 2023;45:3479
    https://doi.org/10.3390/cimb45040228
  79. Onesimus Mahdi, Mohamad T.H. Baharuldin, Nurul Huda M. Nor, Samaila M. Chiroma, Saravanan Jagadeesan, Mohamad A.M. Moklas. The Neuroprotective Properties, Functions, and Roles of Cannabis sativa in Selected Diseases Related to the Nervous System. CNSAMC 2021;21:20
    https://doi.org/10.2174/1871524921666210127110028
  80. Simon Erridge, Oliver Salazar, Michal Kawka, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammed Sajad, Sushil Beri, Jonathan Hoare, Shaheen Khan, Mark W. Weatherall, Michael Platt, James J. Rucker, Mikael H. Sodergren. An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients. Neuropsychopharm Rep 2021;41:362
    https://doi.org/10.1002/npr2.12183
  81. Ye Wang, Xingming Ji, Xinyi Wang, Mengyu Sun, Cheng Li, Dongmei Wu. The injectable hydrogel loading cannabidiol to regulate macrophage polarization in vitro for the treatment of chronic enteritis. Journal of Applied Biomaterials & Functional Materials 2024;22
    https://doi.org/10.1177/22808000241289022
  82. James Alton Croker, Julie L. Bobitt, Kanika Arora, Brian Kaskie. Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois. Clinical Gerontologist 2021;44:66
    https://doi.org/10.1080/07317115.2020.1797971
  83. Saar Anis, Achinoam Faust-Socher, Diana Sverdlov, Simon Lassman, Neomi Hezi, Omer Anis, Gil Leor, Amos D. Korczyn, Nir Giladi, Tanya Gurevich. A single-center real-life study on the use of medical cannabis in patients with dystonia. Front. Neurol. 2023;14
    https://doi.org/10.3389/fneur.2023.1218300
  84. Nathan Herrmann, Myuri Ruthirakuhan, Damien Gallagher, Nicolaas Paul L.G. Verhoeff, Alex Kiss, Sandra E. Black, Krista L. Lanctôt. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease. The American Journal of Geriatric Psychiatry 2019;27:1161
    https://doi.org/10.1016/j.jagp.2019.05.002
  85. Tomasz Boczek, Ludmila Zylinska. Receptor-Dependent and Independent Regulation of Voltage-Gated Ca2+ Channels and Ca2+-Permeable Channels by Endocannabinoids in the Brain. IJMS 2021;22:8168
    https://doi.org/10.3390/ijms22158168
  86. O. Abu-hadid, J. Jimenez-Shahed. An overview of the pharmacotherapeutics for dystonia: advances over the past decade. Expert Opinion on Pharmacotherapy 2022;23:1927
    https://doi.org/10.1080/14656566.2022.2147823
  87. Andrzej Kwaśnica, Natalia Pachura, Klaudia Masztalerz, Adam Figiel, Aleksandra Zimmer, Robert Kupczyński, Katarzyna Wujcikowska, Angel A. Carbonell-Barrachina, Antoni Szumny, Henryk Różański. Volatile Composition and Sensory Properties as Quality Attributes of Fresh and Dried Hemp Flowers (Cannabis sativa L.). Foods 2020;9:1118
    https://doi.org/10.3390/foods9081118
  88. Rachel M. Kalbfell, Devin J. Rettke, Ken Mackie, Keisuke Ejima, Jaroslaw Harezlak, Isabella L. Alexander, Jim Wager-Miller, Blair D. Johnson, Sharlene D. Newman, Keisuke Kawata. The modulatory role of cannabis use in subconcussive neural injury. iScience 2023;26:106948
    https://doi.org/10.1016/j.isci.2023.106948
  89. Sarah Pirio Richardson, H. A. Jinnah. New approaches to discovering drugs that treat dystonia. Expert Opinion on Drug Discovery 2019;14:893
    https://doi.org/10.1080/17460441.2019.1623785
  90. Dipayan Ghosh, Anitika Kundu, Neha Chaudhary, Sakshi Singh, Karuna Shanker, Birendra Kumar, Narendra Kumar. Morpho-anatomical, phytochemical, and molecular diversity of North-Indian Cannabis sativa L. germplasms for CBD-rich genotypes. Nucleus 2024
    https://doi.org/10.1007/s13237-024-00519-w
  91. Anees Bahji, Arthi Chinna Meyyappan, Emily R. Hawken. Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis. Can J Psychiatry 2020;65:365
    https://doi.org/10.1177/0706743719892717
  92. Cerina Lee, Jessica M. Round, Scott Klarenbach, John G. Hanlon, Elaine Hyshka, Jason R. B. Dyck, Dean T. Eurich. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada. Harm Reduct J 2021;18
    https://doi.org/10.1186/s12954-021-00509-0
  93. J. Patrick Neary, Jyotpal Singh, Jane Alcorn, Robert B. Laprairie, Payam Dehghani, Cameron S. Mang, Bruce H. Bjornson, Thomas Hadjistavropoulos, Holly A. Bardutz, Lanishen Bhagaloo, Zachary Walsh, Michael Szafron, Kim D. Dorsch, Elizabeth S. Thompson. Pharmacological and physiological effects of cannabidiol: a dose escalation, placebo washout study protocol. BMC Neurol 2024;24
    https://doi.org/10.1186/s12883-024-03847-1
  94. Mariana Babayeva, Zvi G. Loewy. Medicinal Plants - Harnessing the Healing Power of Plants. 2024.
    https://doi.org/10.5772/intechopen.1005770
  95. Hernan Santiago Garzón, Manuela Loaiza-Oliva, María Cecilia Martínez-Pabón, Jenniffer Puerta-Suárez, Mayra Alexandra Téllez Corral, Bruno Bueno-Silva, Daniel R. Suárez, David Díaz-Báez, Lina J. Suárez. Antibiofilm and Immune-Modulatory Activity of Cannabidiol and Cannabigerol in Oral Environments—In Vitro Study. Antibiotics 2024;13:342
    https://doi.org/10.3390/antibiotics13040342
  96. William Beedham, Magda Sbai, Isabel Allison, Roisin Coary, David Shipway. Cannabinoids in the Older Person: A Literature Review. Geriatrics 2020;5:2
    https://doi.org/10.3390/geriatrics5010002
  97. Joseph Jankovic. Treatment of tics associated with Tourette syndrome. J Neural Transm 2020;127:843
    https://doi.org/10.1007/s00702-019-02105-w
  98. Gregory Malik Burnett, David A. Gorelick, Kevin P. Hill. Policy Ahead of the Science. Psychiatric Clinics of North America 2022;45:347
    https://doi.org/10.1016/j.psc.2022.05.002
  99. Brianna Costales, Sascha van Boemmel-Wegmann, Almut Winterstein, Richard Segal. Clinical Conditions and Prescription Drug Utilization among Early Medical Marijuana Registrants in Florida. Journal of Psychoactive Drugs 2021;53:185
    https://doi.org/10.1080/02791072.2020.1864069
  100. Symone T. Griffith, Kendra D. Conrow, Michael Go, Mindy L. McEntee, Raminta Daniulaityte, Majia H. Nadesan, Mathew R. Swinburne, Holly A. Shill, Maxwell C.K. Leung. Cannabis use in Parkinson’s disease: Patient access to medical cannabis and physician perspective on product safety. NeuroToxicology 2024;103:198
    https://doi.org/10.1016/j.neuro.2024.05.008
  101. Rafael G. Dos Santos, Francisco S. Guimarães, José Alexandre S. Crippa, Jaime E. C. Hallak, Giordano Novak Rossi, Juliana Mendes Rocha, Antônio W. Zuardi. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opinion on Drug Metabolism & Toxicology 2020;16:517
    https://doi.org/10.1080/17425255.2020.1754793
  102. Misty Pratt, Adrienne Stevens, Micere Thuku, Claire Butler, Becky Skidmore, L. Susan Wieland, Mark Clemons, Salmaan Kanji, Brian Hutton. Benefits and harms of medical cannabis: a scoping review of systematic reviews. Syst Rev 2019;8
    https://doi.org/10.1186/s13643-019-1243-x
  103. Thammanard Charernboon, Tiraya Lerthattasilp, Thitipon Supasitthumrong. Effectiveness of Cannabinoids for Treatment of Dementia: A Systematic Review of Randomized Controlled Trials. Clinical Gerontologist 2021;44:16
    https://doi.org/10.1080/07317115.2020.1742832
  104. James David Adams. Probable Causes of Alzheimer’s Disease. Sci 2021;3:16
    https://doi.org/10.3390/sci3010016